We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Shares of National Research Corporation (NRC - Free Report) have gained 12.8% since the company reported its earnings for the quarter ended March 31, 2025, outperforming the S&P 500 index’s 0.7% growth during the same period. However, over the past month, NRC stock has edged down 0.6%, a milder decline compared to the broader market’s 1.6% drop.
For the first quarter of 2025, NRC reported earnings per share (EPS) of 25 cents compared to 27 cents a year earlier. (See the Zacks Earnings Calendar to stay ahead of market-making news.)
The company’s revenues of $33.6 million denoted a 5% decline from $35.3 million in the year-ago period.
Net income totaled $5.8 million, a 9% decline from $6.4 million in the prior-year quarter. Operating income came in at $8.6 million, slightly below the $8.7 million posted in the first quarter of 2024, reflecting modest operational pressure amid lower revenue and higher interest costs.
National Research Corporation Price, Consensus and EPS Surprise
One of the bright spots in the quarter was the sequential growth in total recurring contract value, marking the second consecutive quarter of improvement. This metric, considered by management as a leading indicator of future revenue growth, suggests that the company’s strategic realignment may be gaining traction.
On the cost side, total operating expenses fell to $25 million from $26.6 million a year earlier, aided by lower direct and selling, general and administrative (SG&A) costs. Direct expenses declined 6% to $13.1 million, while SG&A expenses dropped 8% to $10.4 million. Depreciation and amortization rose modestly to $1.5 million from $1.4 million.
The company also faced a notable rise in interest expense, which surged 49% year over year to $0.9 million, reflecting increased debt utilization, including a new $3.5 million drawdown from its line of credit during the quarter.
Management Commentary
CEO Michael D. Hays emphasized the momentum in rebuilding NRC’s sales force, calling it a “key milestone” that contributed to gains in pipeline, win rates and total sales. He stated that while rebuilding a sales organization is inherently gradual, the results already seen justify a more aggressive push in expanding the team. Hays highlighted the importance of a differentiated market message and broader product offerings in driving sales success.
Hays also credited chief operating officer Helen Hrdy for implementing operational efficiencies that have bolstered the company’s ability to invest in growth while continuing to return value to shareholders.
Notably, NRC announced a leadership transition, with Trent Green set to take over as CEO in June 2025. Introductory meetings with Green are scheduled for June 9 and 10, reinforcing the company’s intent to maintain transparency and engagement with stakeholders during the transition.
Factors Influencing Headline Numbers
The year-over-year decline in revenues and earnings was partially offset by tighter cost controls, but the increase in financing costs weighed on profitability. The company’s use of its revolving credit facility added $3.5 million in debt, while interest expense grew nearly $0.3 million from the previous year. Meanwhile, gross margin trends were not detailed in the earnings release, leaving some ambiguity around core business profitability drivers beyond revenues and operating expenses.
Deferred revenues, a forward-looking indicator, held steady at $15.5 million, suggesting stable contracted business levels, though not expanding materially in the short term.
Other Developments
During the quarter, NRC completed its existing share repurchase program, initially adopted in 2022. On April 25, the board of directors authorized a new repurchase plan for up to one million shares of common stock, signaling a continued commitment to shareholder returns. In addition, the company declared a quarterly dividend of 12 cents per share, payable on July 11 to shareholders of record as of June 27. These capital allocation moves underscore NRC’s strategy to balance reinvestment in growth with direct returns to shareholders.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
NRC Q1 Earnings Dip Y/Y Amid Rising Interest Costs, Shares Up 13%
Shares of National Research Corporation (NRC - Free Report) have gained 12.8% since the company reported its earnings for the quarter ended March 31, 2025, outperforming the S&P 500 index’s 0.7% growth during the same period. However, over the past month, NRC stock has edged down 0.6%, a milder decline compared to the broader market’s 1.6% drop.
For the first quarter of 2025, NRC reported earnings per share (EPS) of 25 cents compared to 27 cents a year earlier. (See the Zacks Earnings Calendar to stay ahead of market-making news.)
The company’s revenues of $33.6 million denoted a 5% decline from $35.3 million in the year-ago period.
Net income totaled $5.8 million, a 9% decline from $6.4 million in the prior-year quarter. Operating income came in at $8.6 million, slightly below the $8.7 million posted in the first quarter of 2024, reflecting modest operational pressure amid lower revenue and higher interest costs.
National Research Corporation Price, Consensus and EPS Surprise
National Research Corporation price-consensus-eps-surprise-chart | National Research Corporation Quote
Other Key Business Metrics
One of the bright spots in the quarter was the sequential growth in total recurring contract value, marking the second consecutive quarter of improvement. This metric, considered by management as a leading indicator of future revenue growth, suggests that the company’s strategic realignment may be gaining traction.
On the cost side, total operating expenses fell to $25 million from $26.6 million a year earlier, aided by lower direct and selling, general and administrative (SG&A) costs. Direct expenses declined 6% to $13.1 million, while SG&A expenses dropped 8% to $10.4 million. Depreciation and amortization rose modestly to $1.5 million from $1.4 million.
The company also faced a notable rise in interest expense, which surged 49% year over year to $0.9 million, reflecting increased debt utilization, including a new $3.5 million drawdown from its line of credit during the quarter.
Management Commentary
CEO Michael D. Hays emphasized the momentum in rebuilding NRC’s sales force, calling it a “key milestone” that contributed to gains in pipeline, win rates and total sales. He stated that while rebuilding a sales organization is inherently gradual, the results already seen justify a more aggressive push in expanding the team. Hays highlighted the importance of a differentiated market message and broader product offerings in driving sales success.
Hays also credited chief operating officer Helen Hrdy for implementing operational efficiencies that have bolstered the company’s ability to invest in growth while continuing to return value to shareholders.
Notably, NRC announced a leadership transition, with Trent Green set to take over as CEO in June 2025. Introductory meetings with Green are scheduled for June 9 and 10, reinforcing the company’s intent to maintain transparency and engagement with stakeholders during the transition.
Factors Influencing Headline Numbers
The year-over-year decline in revenues and earnings was partially offset by tighter cost controls, but the increase in financing costs weighed on profitability. The company’s use of its revolving credit facility added $3.5 million in debt, while interest expense grew nearly $0.3 million from the previous year. Meanwhile, gross margin trends were not detailed in the earnings release, leaving some ambiguity around core business profitability drivers beyond revenues and operating expenses.
Deferred revenues, a forward-looking indicator, held steady at $15.5 million, suggesting stable contracted business levels, though not expanding materially in the short term.
Other Developments
During the quarter, NRC completed its existing share repurchase program, initially adopted in 2022. On April 25, the board of directors authorized a new repurchase plan for up to one million shares of common stock, signaling a continued commitment to shareholder returns. In addition, the company declared a quarterly dividend of 12 cents per share, payable on July 11 to shareholders of record as of June 27. These capital allocation moves underscore NRC’s strategy to balance reinvestment in growth with direct returns to shareholders.